CAS: 1187990-87-9
Ref: AN-AG0096T2
5mg | 47.00 € | |
10mg | 59.00 € | |
25mg | 112.00 € | |
50mg | 157.00 € | |
100mg | 189.00 € |
Estimated delivery in United States, on Friday 3 May 2024
MK-8617
CAS:1187990-87-9
MK-8617 is an orally available HIF PHD1 3 pan-inhibitor, inhibiting PHD1/2/3 (IC50: 1.0/1.0/14 nM).
Formula:
C24H21N5O4
Purity:
99.63%
Color and Shape:
Solid
Molecular weight:
443.45
Ref: TM-T4106
1mg | 35.00 € | |
2mg | 47.00 € | |
5mg | 69.00 € | |
10mg | 96.00 € | |
25mg | 166.00 € | |
50mg | 304.00 € | |
100mg | 452.00 € | |
200mg | 644.00 € | |
500mg | 1,013.00 € | |
1ml*10 (DMSO) | 84.00 € |
Estimated delivery in United States, on Friday 10 May 2024
N-[bis(4-methoxyphenyl)methyl]-6-oxo-2-(pyridazin-3-yl)-1,6-dihydropyrimidine-5-carboxamide
CAS:1187990-87-9
Purity:
95%
Molecular weight:
443.4630126953125
Ref: 10-F811127
50mg | To inquire | |
100mg | To inquire | |
200mg | To inquire |
Estimated delivery in United States, on Monday 13 May 2024
MK 8617
CAS:1187990-87-9
Hypoxia inducible prolyl hydroxylase 1-3 (HIF PHD 1-3) inhibitor
Formula:
C24H21N5O4
Purity:
Min. 95%
Molecular weight:
443.45 g/mol
Ref: 3D-BM170837
10mg | To inquire | |
50mg | To inquire |
Estimated delivery in United States, on Friday 14 Jun 2024